Neomycin Sulfate

Producers shown on SFDA

(Record date:27/08/2021）

Producers shown on EP

(Quoted from EP website；record date:29/10/2021）

Producer:Founded in 1968, Sichuan Long March Pharmaceutical Co., Ltd. is located in Leshan City, a famous historical and cultural city in Southwest Sichuan Province. Long March, directly controlled by Sichuan Lanyan Investment Group Co., Ltd. (hereinafter referred to Lanyan Group), is a large antibiotic API production enterprise in Southwest China, which is the core enterprise of key medical pharmaceutical industry of Lanyan Group.

With more than 50 years’ experience in production and operation since its establishment, Long March has been in strict accordance with the national industrial policy and the production and operation regulations of the pharmaceutical industry, adhering to the business philosophy of responsibility, quality, integrity and innovation, taking the construction of modern medical and pharmaceutical enterprise as the development goal, and constantly growing and developing. The company's business scope covers biological fermentation, chemical synthesis, pharmaceutical machinery and other fields, with more than 100 products. The main API products are sold to 63 countries and regions such as the United States, Europe, Japan, Australia, Africa and Southeast Asia. The CY and Shanjiang trademarks are well-known at home and abroad. The company has multiple production lines which have passed the GMP certification inspection in China. In 1982, the company took the lead in China and passed the FDA certification inspection for 14 consecutive times. Eight products were approved to enter the U.S. market successively. At the same time, it took the lead in successfully registering in the European Union in 2002 and passed the EDQM certification inspection for three times in a row. 

Staff size:400-499 persons

Registered capital:RMB 128.22 million

Producer:Yichang Sanxia Pharmaceutical Co., Ltd.is a wholly-owned subsidiary of humanwell Pharmaceutical Group. The company is a national high-tech enterprise. It is a comprehensive biopharmaceutical enterprise that studies and produces antibiotic API, amino acid series high-capacity injections and animal drug preparations.

The company is a large global supplier of neomycin sulfate API. Its subdivided product line covers neomycin sulfate for animals, Fraxinus sulfate, neomycin sulfate for prescription people in the United States, etc. its products have passed the certification of FDA and CEP of the European Union, with a global market share of more than 80%. Neomycin sulfate has won the title of "single champion product" in the national manufacturing industry. The company is also one of the earliest manufacturers of amino acid high-volume injections in China. At present, it mainly produces compound amino acid infusion and other basic infusion with product specifications of 3AA, 6Aa, 9aa, 15aa, 17aa, 17aa-i and 18AA, and the product specifications of various soft bags and glass bottles have reached 46. Among them, "Three Gorges brand" series amino acid high-volume injections are recognized as "famous brand products" and "high-quality products" in Hubei Province. The sales volume of compound amino acid injection 3AA accounts for more than 50% in China.

Staff size:1000-1999 persons

Registered capital:RMB 390 million